These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 571607)

  • 1. Videotaping: the evaluation of stereotypic effects of antiparkinsonian agents.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Jan; 10(1):161-4. PubMed ID: 571607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
    Riffee WH; Wilcox RE; Smith RV
    Eur J Pharmacol; 1979 Mar; 54(3):273-7. PubMed ID: 570924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the effects of apomorphine in mammals and frogs.
    Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):387-9. PubMed ID: 16912885
    [No Abstract]   [Full Text] [Related]  

  • 5. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
    Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 7. N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
    Verma A; Kulkarni SK
    Ann N Y Acad Sci; 1995 Sep; 765():327. PubMed ID: 7486633
    [No Abstract]   [Full Text] [Related]  

  • 8. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity.
    Wilcox RE; Smith RV; Anderson JA; Riffee WH
    Pharmacol Biochem Behav; 1980 Jan; 12(1):29-33. PubMed ID: 7189285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings].
    Costall B; Naylor RJ; Nohria V
    Br J Pharmacol; 1978 Jun; 63(2):381P-382P. PubMed ID: 27276
    [No Abstract]   [Full Text] [Related]  

  • 10. Circadian rhythm of apomorphine-induced stereotypy in rats.
    Nakano S; Hara C; Ogawa N
    Pharmacol Biochem Behav; 1980 Mar; 12(3):459-61. PubMed ID: 7190288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary report on the action of imipramine and antiparkinsonian agents on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Jpn J Pharmacol; 1974 Oct; 24(5):809-10. PubMed ID: 4477250
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 13. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P; Charpentier S; Costentin J
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of carbon disulphide on the stereotypic effect of dopamine agonists.
    Magos L
    Eur J Pharmacol; 1976 Mar; 36(1):257-8. PubMed ID: 944133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
    Lee CY; Double KL; Crocker AD
    Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse tolerance to amphetamine of mice bearing unilateral striatal lesions: effect upon the circling response to apomorphine.
    Echols SD
    Life Sci; 1979 Feb; 24(8):691-6. PubMed ID: 571504
    [No Abstract]   [Full Text] [Related]  

  • 17. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease.
    Löschmann PA; Eblen F; Wüllner U; Wachtel H; Kockgether T
    Eur J Pharmacol; 1995 Sep; 284(1-2):129-34. PubMed ID: 8549615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.
    Mogilnicka E; Braestrup C
    J Pharm Pharmacol; 1976 Mar; 28(3):253-5. PubMed ID: 6705
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.